CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 8-K Event Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 48,750 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 42,250 shares (grant or award)
- 4 Grant or award See Remarks acquired 121,875 shares (grant or award)
- 4 Grant or award See Remarks acquired 34,125 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 2,000 shares at an average $10.41 ($20,811)
- 8-K Event Other events
- 4 Open-market buy Director bought 4,000 shares at $9.75 ($39,000)
- 4 Open-market buy Director bought 10,000 shares at $12.37 ($123,700)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 1,250,000 shares at $12.00 ($15,000,000)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
Page 14 of 20 · 383 filings